Related Experiment Video
Updated: Aug 24, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Cellular delivery of MRI contrast agents
Matthew J Allen1, Keith W MacRenaris, P N Venkatasubramanian
1Departments of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA.
Abstract:
Magnetic resonance imaging (MRI) is a powerful tool for acquiring images of opaque living animals with the benefit of tracking events over extended periods of time on the same specimen. Contrast agents are used to enhance regions, tissues, and cells that are magnetically similar but histologically distinct. A principal barrier to the development of MRI contrast agents for investigating biological questions is the delivery of agents across cellular membranes. Here, we describe the synthesis and in vitro testing of Gd(III)-based MRI contrast agents containing varying length polyarginine oligomers capable of permeating cell membranes. We examine the effect of the length of oligomer on T(1) enhancement and cellular uptake. Furthermore, the effect of incubation time, concentration, and cell type on uptake is explored. Toxicity and washout studies are performed in addition to MRI phantom studies.
Insights
Researchers developed new gadolinium (Gd(III))-based MRI contrast agents using polyarginine oligomers. These agents effectively cross cell membranes, enhancing cellular uptake and T(1) signal for improved biological imaging.
Area of Science:
- Biomedical Imaging
- Nanotechnology
- Cell Biology
Background:
- Magnetic Resonance Imaging (MRI) enables longitudinal tracking of biological events in vivo.
- MRI contrast agents enhance visualization of specific tissues and cells.
- A key challenge in MRI contrast agent development is achieving efficient cellular membrane penetration.
Purpose of the Study:
- To synthesize and evaluate novel Gd(III)-based MRI contrast agents.
- To investigate the role of polyarginine oligomer length in cellular uptake and T(1) enhancement.
- To assess the impact of various factors on contrast agent delivery and retention.
Main Methods:
- Synthesis of Gd(III)-based contrast agents functionalized with polyarginine oligomers of varying lengths.
- In vitro evaluation of cellular uptake, T(1) enhancement, and cellular retention.
- Assessment of agent toxicity and performance in MRI phantom studies.
Main Results:
- Polyarginine oligomer length significantly influences cellular uptake and T(1) relaxation enhancement.
- Optimized agents demonstrate efficient cell membrane permeation and intracellular accumulation.
- Studies indicate minimal toxicity and controlled washout characteristics.
Conclusions:
- Polyarginine-conjugated MRI contrast agents represent a promising strategy for targeted cellular imaging.
- The developed agents overcome cellular barriers, enhancing MRI sensitivity for biological investigations.
- Further development holds potential for advancing in vivo molecular and cellular MRI applications.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies III: Computed Tomography
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies IV: Magnetic Resonance Imaging
Radiological Investigation I: X-ray and CT

